Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Altered resting-state functional connectivity in individuals at risk for Alzheimer's disease, a longitudinal study

  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Maturana-Quijada, Pablo
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Juaneda-Seguí, Asier
  • Guinea-Izquierdo, Andrés
  • Gascon Bayarri, Jordi|||0000-0002-9422-937X
  • Reñé-Ramírez, Ramón
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Resting-state functional connectivity magnetic resonance imaging (rs-fMRI) is a sensitive tool for detecting early brain changes associated with Alzheimer's disease, even in its preclinical stages. Amnestic mild cognitive impairment (aMCI) and late-life depression (LLD) are two prevalent conditions in older adults that significantly elevate the risk of cognitive decline and dementia. This study aimed to elucidate the underlying neurobiological substrates by longitudinally identifying and comparing distinct connectivity patterns in aMCI subjects and LLD patients, and by examining the associations between these patterns and clinical measures of cognitive and mood impairments. The study included three groups: 26 healthy controls (HCs), 15 individuals with aMCI, and 21 patients with LLD. All participants underwent rs-fMRI and neuropsychological assessments at baseline and at a 2-year follow-up. Functional connectivity was analyzed using a group Independent Component Analysis (ICA) model to investigate both group differences and longitudinal changes over time. At baseline, individuals with aMCI exhibited reduced functional connectivity in the precuneus, whereas LLD patients showed decreased connectivity in frontal, insular, and postcentral regions alongside increased connectivity in posterior parietal and cuneal cortices. Correlation analyses revealed that lower baseline insular connectivity predicted higher depressive symptoms at follow-up in aMCI subjects. In LLD, reduced baseline precuneus connectivity was associated with better two-year outcomes in global cognition and long-term memory. This study provides evidence of distinct alterations in resting-state functional connectivity in individuals with aMCI and LLD, underscoring region-specific vulnerabilities that may contribute to cognitive decline and depressive symptomatology in older adults.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Gradogna, Antonella
  • Laparra-Cuervo, Lara
  • Solsona, Carles
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Lakadamyali, Melike
  • Estévez, Raúl|||0000-0003-1579-650X
Volume-regulated anion channels (VRACs) play an important role in controlling cell volume by opening upon cell swelling. Recent work has shown that heteromers of LRRC8A with other LRRC8 members (B, C, D, and E) form the VRAC. Here, we used Xenopus oocytes as a simple system to study LRRC8 proteins. We discovered that adding fluorescent proteins to the C-terminus resulted in constitutive anion channel activity. Using these constructs, we reproduced previous findings indicating that LRRC8 heteromers mediate anion and osmolyte flux with subunit-dependent kinetics and selectivity. Additionally, we found that LRRC8 heteromers mediate glutamate and ATP flux and that the inhibitor carbenoxolone acts from the extracellular side, binding to probably more than one site. Our results also suggest that the stoichiometry of LRRC8 heteromers is variable, with a number of subunits ≥6, and that the heteromer composition depends on the relative expression of different subunits. The system described here enables easy structure-function analysis of LRRC8 proteins.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Illuminating phenylazopyridines to photoswitch metabotropic glutamate receptors, from the flask to the animals

  • Gómez-Santacana, Xavier|||0000-0001-8830-0494
  • Pittolo, Silvia|||0000-0002-5673-1692
  • Rovira, Xavier|||0000-0002-9764-9927
  • Lopez, Marc
  • Zussy, Charleine
  • Dalton, James A. R.|||0000-0002-5279-4581
  • Faucherre, Adèle
  • Jopling, Chris
  • Pin, Jean-Philippe|||0000-0002-1423-345X
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Goudet, Cyril|||0000-0002-8255-3535
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Llebaria, Amadeu|||0000-0002-8200-4827
Phenylazopyridines are photoisomerizable compounds with high potential to control biological functions with light. We have obtained a series of phenylazopyridines with light dependent activity as negative allosteric modulators (NAM) of metabotropic glutamate receptor subtype 5 (mGlu). Here we describe the factors needed to achieve an operational molecular photoisomerization and its effective translation into in vitro and in vivo receptor photoswitching, which includes zebrafish larva motility and the regulation of the antinociceptive effects in mice. The combination of light and some specific phenylazopyridine ligands displays atypical pharmacological profiles, including light-dependent receptor overactivation, which can be observed both in vitro and in vivo. Remarkably, the localized administration of light and a photoswitchable compound in the peripheral tissues of rodents or in the brain amygdalae results in an illumination-dependent analgesic effect. The results reveal a robust translation of the phenylazopyridine photoisomerization to a precise photoregulation of biological activity. The cis - trans photoisomerization of phenylazopyridines, allowing mGlu receptor activity photoswitching in cells, is used in vivo to control zebrafish motility with light and analgesia in mice including peripheral and brain localized illumination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Optical control of pain in vivo with a photoactive mGlu receptor negative allosteric modulator

  • Font Inglès, Joan|||0000-0001-8416-1909
  • López Cano, Marc|||0000-0001-8885-3726
  • Notartomaso, Serena|||0000-0003-4374-9233
  • Scarselli, Pamela|||0000-0002-4245-0849
  • Di Pietro, Paola|||0000-0003-1327-1961
  • Bresolí-Obach, Roger|||0000-0002-7819-7750
  • Battaglia, Giuseppe|||0000-0001-7571-3417
  • Malhaire, Fanny
  • Rovira, Xavier|||0000-0002-9764-9927
  • Catena, Juanlo|||0000-0002-2423-5926
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Pin, Jean-Philippe|||0000-0002-1423-345X
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Goudet, Cyril|||0000-0002-8255-3535
  • Nonell, Santi|||0000-0002-8900-5291
  • Nicoletti, Ferdinando|||0000-0003-0917-443X
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Ciruela, Francisco|||0000-0003-0832-3739
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug's release, which effectively controls mGlu receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons

  • Urrea, Laura
  • Segura-Feliu, Miriam
  • Masuda-Suzukake, Masami
  • Hervera Abad, Arnau|||0000-0001-8362-369X
  • Pedraz, Lucas
  • García Aznar, José Manuel
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Samitier, Josep|||0000-0002-1140-3679
  • Torrents, Eduard|||0000-0002-3010-1609
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Gavín, Rosalina|||0000-0003-1982-2162
  • Hagesawa, Masato
  • Rio, Jose Antonio del|||0000-0002-5214-4909
The cellular prion protein, encoded by the gene Prnp, has been reported to be a receptor of β-amyloid. Their interaction is mandatory for neurotoxic effects of βamyloid oligomers. In this study, we aimed to explore whether the cellular prion protein participates in the spreading of α-synuclein. Results demonstrate that Prnp expression is not mandatory for α-synuclein spreading. However, although the pathological spreading of αsynuclein can take place in the absence of Prnp, αsynuclein expanded faster in PrPC-overexpressing mice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BDNF genetic variants and methylation, effects on cognition in major depressive disorder

  • Ferrer, Alex|||0000-0002-3040-1177
  • Labad, Javier|||0000-0003-2214-1886
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Barrachina, Marta
  • Costas, Javier|||0000-0003-0306-3990
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Crespo, José M.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
Brain-derived neurotrophic factor (BDNF) gene regulation has been linked to the pathophysiology of major depressive disorder (MDD). MDD patients show cognitive deficits, and altered BDNF regulation has a relevant role in neurocognitive functions. Our goal was to explore the association between BDNF genetic and epigenetic variations with neurocognitive performance in a group of MDD patients and healthy controls considering possible modulating factors. The sample included 134 subjects, 64 MDD patients, and 70 healthy controls. Clinical data, childhood maltreatment, and neurocognitive performance were assessed in all participants. Eleven single nucleotide polymorphisms (SNPs) and two promoter regions in the BDNF gene were selected for genotype and methylation analysis. The role of interactions between BDNF genetic and epigenetic variations with MDD diagnosis, sex, and Childhood Trauma Questionnaire (CTQ) scores was also explored. We observed significant associations between neurocognitive performance and two BDNF SNPs (rs908867 and rs925946), an effect that was significantly mediated by methylation values at specific promoter I sites. We identified significant associations between neurocognitive results and methylation status as well as its interactions with MDD diagnosis, sex, and CTQ scores. Our results support the hypothesis that BDNF gene SNPs and methylation status, as well as their interactions with modulating factors, can influence cognition. Further studies are required to confirm the effect of BDNF variations and cognitive function in larger samples.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Control of glutamate release by complexes of adenosine and cannabinoid receptors

  • Köfalvi, Attila
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Cai, Ning-Sheng
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ferreira, Samira G.
  • Guixà González, Ramon|||0000-0003-0397-9800
  • Sánchez Soto, Marta
  • Yano, Hideaki
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Cunha, Rodrigo A.
  • Sebastião, Ana Maria
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Casadó, Vicent|||0000-0002-1764-3825
  • Ferré, Sergi|||0000-0002-1747-1779
It has been hypothesized that heteromers of adenosine A receptors (A2AR) and cannabinoid CB receptors (CB1R) localized in glutamatergic nerve terminals mediate the integration of adenosine and endocannabinoid signaling involved in the modulation of striatal excitatory neurotransmission. Previous studies have demonstrated the existence of A2AR-CB1R heteromers in artificial cell systems. A dependence of A2AR signaling for the Gi protein-mediated CB1R signaling was described as one of its main biochemical characteristics. However, recent studies have questioned the localization of functionally significant A2AR-CB1R heteromers in striatal glutamatergic terminals. Using a peptide-interfering approach combined with biophysical and biochemical techniques in mammalian transfected cells and computational modeling, we could establish a tetrameric quaternary structure of the A2AR-CB1R heterotetramer. This quaternary structure was different to the also tetrameric structure of heteromers of A2AR with adenosine A receptors or dopamine D receptors, with different heteromeric or homomeric interfaces. The specific quaternary structure of the A2A-CB1R, which depended on intermolecular interactions involving the long C-terminus of the A2AR, determined a significant A2AR and Gs protein-mediated constitutive activation of adenylyl cyclase. Using heteromer-interfering peptides in experiments with striatal glutamatergic terminals, we could then demonstrate the presence of functionally significant A2AR-CB1R heteromers with the same biochemical characteristics of those studied in mammalian transfected cells. First, either an A2AR agonist or an A2AR antagonist allosterically counteracted Gi-mediated CB1R agonist-induced inhibition of depolarization-induced glutamate release. Second, co-application of both an A2AR agonist and an antagonist cancelled each other effects. Finally, a CB1R agonist inhibited glutamate release dependent on a constitutive activation of A2AR by a canonical Gs-Gi antagonistic interaction at the adenylyl cyclase level. We demonstrate that the well-established cannabinoid-induced inhibition of striatal glutamate release can mostly be explained by a CB1R-mediated counteraction of the A2AR-mediated constitutive activation of adenylyl cyclase in the A2AR-CB1R heteromer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A-Dopamine D Receptor Heterotetramers and Adenylyl Cyclase

  • Ferré, Sergi|||0000-0002-1747-1779
  • Bonaventura, Jordi
  • Zhu, Wendy
  • Hatcher-Solis, Candice
  • Taura, Jaume
  • Quiroz, César
  • Cai, Ning-Sheng
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Kravitz, Alexxai V.
  • Thompson, Kimberly R.
  • Tomasi, Dardo G.
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Lluís, Carme
  • Dessauer, Carmen W.
  • Volkow, Nora|||0000-0001-6668-0908
  • Casadó, Vicent|||0000-0002-1764-3825
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Logothetis, Diomedes E.
  • Zwilling, Daniel
The central adenosine system and adenosine receptors play a fundamental role in the modulation of dopaminergic neurotransmission. This is mostly achieved by the strategic co-localization of different adenosine and dopamine receptor subtypes in the two populations of striatal efferent neurons, striatonigral and striatopallidal, that give rise to the direct and indirect striatal efferent pathways, respectively. With optogenetic techniques it has been possible to dissect a differential role of the direct and indirect pathways in mediating "Go" responses upon exposure to reward-related stimuli and "NoGo" responses upon exposure to non-rewarded or aversive-related stimuli, respectively, which depends on their different connecting output structures and their differential expression of dopamine and adenosine receptor subtypes. The striatopallidal neuron selectively expresses dopamine D receptors (D2R) and adenosine A receptors (A2AR), and numerous experiments using multiple genetic and pharmacological in vitro, in situ and in vivo approaches, demonstrate they can form A2AR-D2R heteromers. It was initially assumed that different pharmacological interactions between dopamine and adenosine receptor ligands indicated the existence of different subpopulations of A2AR and D2R in the striatopallidal neuron. However, as elaborated in the present essay, most evidence now indicates that all interactions can be explained with a predominant population of striatal A2AR-D2R heteromers forming complexes with adenylyl cyclase subtype 5 (AC5). The A2AR-D2R heteromer has a tetrameric structure, with two homodimers, which allows not only multiple allosteric interactions between different orthosteric ligands, agonists, and antagonists, but also the canonical Gs-Gi antagonistic interaction at the level of AC5. We present a model of the function of the A2AR-D2R heterotetramer-AC5 complex, which acts as an integrative device of adenosine and dopamine signals that determine the excitability and gene expression of the striatopallidal neurons. The model can explain most behavioral effects of A2AR and D2R ligands, including the psychostimulant effects of caffeine. The model is also discussed in the context of different functional striatal compartments, mainly the dorsal and the ventral striatum. The current accumulated knowledge of the biochemical properties of the A2AR-D2R heterotetramer-AC5 complex offers new therapeutic possibilities for Parkinson's disease, schizophrenia, SUD and other neuropsychiatric disorders with dysfunction of dorsal or ventral striatopallidal neurons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Angiotensin II type 1/adenosine A receptor oligomers, a novel target for tardive dyskinesia

  • Oliveira, Paulo A. de|||0000-0002-0852-4920
  • Dalton, James A. R.|||0000-0002-5279-4581
  • López Cano, Marc|||0000-0001-8885-3726
  • Ricarte, Adrià
  • Morató, Xavier|||0000-0002-3012-2864
  • Matheus, Filipe C.
  • Cunha, Andréia S.
  • Müller, Christa E.
  • Takahashi, Reinaldo N.
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Prediger, Rui D.
  • Ciruela, Francisco|||0000-0003-0832-3739
Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D receptors (DRs). Striatal DR functioning may be finely regulated by either adenosine A receptor (AR) or angiotensin receptor type 1 (ATR) through putative receptor heteromers. Here, we examined whether AR and ATR may oligomerize in the striatum to synergistically modulate dopaminergic transmission. First, by using bioluminescence resonance energy transfer, we demonstrated a physical ATR-AR interaction in cultured cells. Interestingly, by protein-protein docking and molecular dynamics simulations, we described that a stable heterotetrameric interaction may exist between ATR and AR bound to antagonists (i.e. losartan and istradefylline, respectively). Accordingly, we subsequently ascertained the existence of ATR/AR heteromers in the striatum by proximity ligation in situ assay. Finally, we took advantage of a TD animal model, namely the reserpine-induced vacuous chewing movement (VCM), to evaluate a novel multimodal pharmacological TD treatment approach based on targeting the ATR/AR complex. Thus, reserpinized mice were co-treated with sub-effective losartan and istradefylline doses, which prompted a synergistic reduction in VCM. Overall, our results demonstrated the existence of striatal ATR/AR oligomers with potential usefulness for the therapeutic management of TD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lower Locus Coeruleus MRI intensity in patients with late-life major depression

  • Guinea-Izquierdo, Andrés
  • Giménez, Mónica|||0000-0003-2757-0145
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Canal-Noguer, Pol
  • Blasco, Gerard|||0000-0002-5302-0625
  • Gascón, Jordi
  • Reñé, Ramon
  • Rico, Inmaculada
  • Camins, Àngels|||0000-0003-2678-8134
  • Aguilera, Carlos
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
The locus coeruleus (LC) is the major noradrenergic source in the central nervous system. Structural alterations in the LC contribute to the pathophysiology of different neuropsychiatric disorders, which may increase to a variable extent the likelihood of developing neurodegenerative conditions. The characterization of such alterations may therefore help to predict progression to neurodegenerative disorders. Despite the LC cannot be visualized with conventional magnetic resonance imaging (MRI), specific MRI sequences have been developed to infer its structural integrity. We quantified LC signal Contrast Ratios (LCCRs) in late-life major depressive disorder (MDD) (n = 37, 9 with comorbid aMCI), amnestic Mild Cognitive Impairment (aMCI) (n = 21, without comorbid MDD), and healthy controls (HCs) (n = 31), and also assessed the putative modulatory effects of comorbidities and other clinical variables. LCCRs were lower in MDD compared to aMCI and HCs. While no effects of aMCI comorbidity were observed, lower LCCRs were specifically observed in patients taking serotonin/norepinephrine reuptake inhibitors (SNRIs). Our results do not support the hypothesis that lower LCCRs characterize the different clinical groups that may eventually develop a neurodegenerative disorder. Conversely, our results were specifically observed in patients with late-life MDD taking SNRIs. Further research with larger samples is warranted to ascertain whether medication or particular clinical features of patients taking SNRIs are associated with changes in LC neurons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation

  • Herraiz-Martínez, Adela
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Llach, Anna|||0000-0002-7486-1079
  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Nolla-Colomer, Carme|||0000-0002-7681-3556
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Izquierdo-Castro, Paloma|||0000-0003-1494-5665
  • Benitez, Ivan David|||0000-0002-3558-5948
  • Benítez, Raúl|||0000-0002-8782-9406
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Rodríguez-Font, Enrique|||0000-0001-5895-4219
  • Viñolas, Xavier|||0000-0002-8243-1271
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Cinca, Juan|||0000-0003-4819-4265
  • Madsen, Leif Hove|||0000-0001-5493-3998
Atrial fibrillation (AF) has been associated with intracellular calcium disturbances in human atrial myocytes, but little is known about the potential influence of sex and we here aimed to address this issue. Alterations in calcium regulatory mechanisms were assessed in human atrial myocytes from patients without AF or with long-standing persistent or permanent AF. Patch-clamp measurements revealed that L-type calcium current (I ) density was significantly smaller in males with than without AF (-1.15 ± 0.37 vs. -2.06 ± 0.29 pA/pF) but not in females with AF (-1.88 ± 0.40 vs. -2.21 ± 0.0.30 pA/pF). In contrast, transient inward currents (I ) were more frequent in females with than without AF (1.92 ± 0.36 vs. 1.10 ± 0.19 events/min) but not in males with AF. Moreover, confocal calcium imaging showed that females with AF had more calcium spark sites than those without AF (9.8 ± 1.8 vs. 2.2 ± 1.9 sites/µm 2) and sparks were wider (3.0 ± 0.3 vs. 2.2 ± 0.3 µm) and lasted longer (79 ± 6 vs. 55 ± 8 ms), favouring their fusion into calcium waves that triggers I s and afterdepolarizations. This was linked to higher ryanodine receptor phosphorylation at s2808 in women with AF, and inhibition of adenosine A or beta-adrenergic receptors that modulate s2808 phosphorylation was able to reduce the higher incidence of I in women with AF. Perturbations of the calcium homoeostasis in AF is sex-dependent, concurring with increased spontaneous SR calcium release-induced electrical activity in women but not in men, and with diminished I density in men only. This work was supported by grants from The Spanish Ministry of Science Innovation and Universities [.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects

  • López Cano, Marc|||0000-0001-8885-3726
  • Font Inglès, Joan|||0000-0001-8416-1909
  • Aso, Ester|||0000-0003-1836-1747
  • Sahlholm, Kristoffer|||0000-0001-6536-1972
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Giraldo, Jesús|||0000-0001-7082-4695
  • De Koninck, Yves|||0000-0002-5779-9330
  • Hernando, Jordi|||0000-0002-1126-4138
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
Background and Purpose: Opioid-based drugs are the gold standard medicines for pain relief. However, tolerance and several side effects (i.e. constipation and dependence) may occur upon chronic opioid administration. Photopharmacology is a promising approach to improve the benefit/risk profiles of these drugs. Thus, opioids can be locally activated with high spatiotemporal resolution, potentially minimizing systemic-mediated adverse effects. Here, we aimed at developing a morphine photo-derivative (photocaged morphine), which can be activated upon light irradiation both in vitro and in vivo. Experimental Approach: Light-dependent activity of pc-morphine was assessed in cell-based assays (intracellular calcium accumulation and electrophysiology) and in mice (formalin animal model of pain). In addition, tolerance, constipation and dependence were investigated in vivo using experimental paradigms. Key results: In mice, pc-morphine was able to elicit antinociceptive effects, both using external light-irradiation (hind paw) and spinal cord implanted fibre-optics. In addition, remote morphine photoactivation was devoid of common systemic opioid-related undesired effects, namely, constipation, tolerance to the analgesic effects, rewarding effects and naloxone-induced withdrawal. Conclusion and Implications: Light-dependent opioid-based drugs may allow effective analgesia without the occurrence of tolerance or the associated and severe opioid-related undesired effects.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Optical control of adenosine A3 receptor function in psoriasis

  • López Cano, Marc|||0000-0001-8885-3726
  • Filgaira, Ingrid|||0000-0002-9886-3925
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Tosh, Dilip K.
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Ciruela, Francisco|||0000-0003-0832-3739
Psoriasis is a chronic and relapsing inflammatory skin disease lacking a cure that affects approximately 2% of the population. Defective keratinocyte proliferation and differentiation, and aberrant immune responses are major factors in its pathogenesis. Available treatments for moderate to severe psoriasis are directed to immune system causing systemic immunosuppression over time, and thus concomitant serious side effects (i.e. infections and cancer) may appear. In recent years, the G protein-coupled A receptor (AR) for adenosine has been suggested as a novel and very promising therapeutic target for psoriasis. Accordingly, selective, and high affinity AR agonists are known to induce robust anti-inflammatory effects in animal models of autoimmune inflammatory diseases. Here, we demonstrated the efficacy of a selective AR agonist, namely MRS5698, in preventing the psoriatic-like phenotype in the IL-23 mouse model of psoriasis. Subsequently, we photocaged this molecule with a coumarin moiety to yield the first photosensitive AR agonist, MRS7344, which in photopharmacological experiments prevented the psoriatic-like phenotype in the IL-23 animal model. Thus, we have demonstrated the feasibility of using a non-invasive, site-specific, light-directed approach to psoriasis treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist

  • Taura, Jaume
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Squarcialupi, Lucia
  • López Cano, Marc|||0000-0001-8885-3726
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
G protein-coupled adenosine receptors are promising therapeutic targets for a wide range of neuropathological conditions, including Parkinson's disease (PD). However, the ubiquity of adenosine receptors and the ultimate lack of selectivity of certain adenosine-based drugs have frequently diminished their therapeutic use. Photopharmacology is a novel approach that allows the spatiotemporal control of receptor function, thus circumventing some of these limitations. Here, we aimed to develop a light-sensitive caged adenosine A receptor (A R) antagonist to photocontrol movement disorders. We synthesized MRS7145 by blocking with coumarin the 5-amino position of the selective A R antagonist SCH442416, which could be photoreleased upon violet light illumination (405 nm). First, the light-dependent pharmacological profile of MRS7145 was determined in A R-expressing cells. Upon photoactivation, MRS7145 precluded A R ligand binding and agonist-induced cAMP accumulation. Next, the ability of MRS7145 to block A R in a light-dependent manner was assessed in vivo. To this end, A R antagonist-mediated locomotor activity potentiation was evaluated in brain (striatum) fiber-optic implanted mice. Upon irradiation (405 nm) of the dorsal striatum, MRS7145 induced significant hyperlocomotion and counteracted haloperidol-induced catalepsy and pilocarpine-induced tremor. Finally, its efficacy in reversing motor impairment was evaluated in a PD animal model, namely the hemiparkinsonian 6-hydroxydopamine (6-OHDA)-lesioned mouse. Photo-activated MRS7145 was able to potentiate the number of contralateral rotations induced by L-3,4-dihydroxyphenylalanine (L-DOPA). Overall, MRS7145 is a new light-operated A R antagonist with potential utility to manage movement disorders, including PD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adenosine a2a receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Duroux, Romain|||0000-0001-7099-1469
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Montiel, José|||0000-0002-3791-5218
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia seen in clinical practice. While some clinical parameters may predict the transition from paroxysmal to persistent AF, the molecular mechanisms behind the AF perpetuation are poorly understood. Thus, oxidative stress, calcium overload and inflammation, among others, are believed to be involved in AF-induced atrial remodelling. Interestingly, adenosine and its receptors have also been related to AF development and perpetuation. Here, we investigated the expression of adenosine A2A receptor (A2AR) both in right atrium biopsies and peripheral blood mononuclear cells (PBMCs) from non-dilated sinus rhythm (ndSR), dilated sinus rhythm (dSR) and AF patients. In addition, plasma adenosine content and adenosine deaminase (ADA) activity in these subjects were also determined. Our results revealed increased A2AR expression in the right atrium from AF patients, as previously described. Interestingly, increased levels of adenosine content and reduced ADA activity in plasma from AF patients were detected. An increase was observed when A2AR expression was assessed in PBMCs from AF subjects. Importantly, a positive correlation (P=0.001) between A2AR expression in the right atrium and PBMCs was observed. Overall, these results highlight the importance of the A2AR in AF and suggest that the evaluation of this receptor in PBMCs may be potentially be useful in monitoring disease severity and the efficacy of pharmacological treatments in AF patients.